<a href="https://laohu8.com/S/THRD">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Plans to Terminate SEC Reporting Obligations
Third Harmonic Bio Inc. announced a regulatory development regarding its stock listing. On July 31, 2025, the company filed a Form 25 with the Securities and Exchange Commission $(SEC.UK)$ to voluntarily delist its common stock under Section 12(b) of the Securities Exchange Act of 1934. The delisting will become effective around August 10, 2025. Consequently, trading of the company's stock on Nasdaq was suspended before the market opened on July 31, 2025. Additionally, Third Harmonic Bio plans to file a Form 15 with the SEC on August 11, 2025, to terminate the registration of its common stock under Section 12(g) of the Exchange Act, suspending its reporting obligations. This move is part of the company's previously approved Plan of Dissolution, with a certificate of dissolution filed on the same day, July 31, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-170428), on July 31, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.